Scpharmaceuticals Net Income
| SCPHDelisted Stock | USD 5.67 0.01 0.18% |
As of the 2nd of February, Scpharmaceuticals has the Coefficient Of Variation of 598.35, semi deviation of 2.34, and Risk Adjusted Performance of 0.1289. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scpharmaceuticals, as well as the relationship between them.
Scpharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Scpharmaceuticals' valuation are provided below:Scpharmaceuticals does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Scpharmaceuticals |
Search Suggestions
| SC | SC | Cryptocurrency |
| SCE-PK | SCE Trust V | Company |
| SCI | Service International | Company |
| SCD | Lmp Capital And | Fund |
| SCC | ProShares UltraShort Consumer | ETF |
| SC | Santander Consumer USA | CompanyDelisted |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Scpharmaceuticals reported net income of (85.15 Million). This is 124.95% lower than that of the Pharmaceuticals sector and 221.56% lower than that of the Health Care industry. The net income for all United States stocks is 114.91% higher than that of the company.
Scpharmaceuticals Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scpharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Scpharmaceuticals could also be used in its relative valuation, which is a method of valuing Scpharmaceuticals by comparing valuation metrics of similar companies.Scpharmaceuticals is currently under evaluation in net income category among its peers.
Scpharmaceuticals Fundamentals
| Return On Equity | -9.34 | |||
| Return On Asset | -0.57 | |||
| Profit Margin | (1.84) % | |||
| Operating Margin | (0.89) % | |||
| Current Valuation | 315.46 M | |||
| Shares Outstanding | 53.68 M | |||
| Shares Owned By Insiders | 5.97 % | |||
| Shares Owned By Institutions | 80.35 % | |||
| Number Of Shares Shorted | 811.77 K | |||
| Price To Book | 28.45 X | |||
| Price To Sales | 6.09 X | |||
| Revenue | 36.33 M | |||
| Gross Profit | 34.21 M | |||
| EBITDA | (77.43 M) | |||
| Net Income | (85.15 M) | |||
| Cash And Equivalents | 55.85 M | |||
| Cash Per Share | 2.04 X | |||
| Total Debt | 52.69 M | |||
| Debt To Equity | 0.32 % | |||
| Current Ratio | 3.72 X | |||
| Book Value Per Share | (0.40) X | |||
| Cash Flow From Operations | (70.54 M) | |||
| Short Ratio | 0.36 X | |||
| Earnings Per Share | (1.81) X | |||
| Target Price | 5.68 | |||
| Number Of Employees | 162 | |||
| Beta | 0.3 | |||
| Market Capitalization | 304.36 M | |||
| Total Asset | 107.52 M | |||
| Retained Earnings | (366.49 M) | |||
| Working Capital | 90.97 M | |||
| Net Asset | 107.52 M |
About Scpharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Scpharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scpharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scpharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Scpharmaceuticals Stock
If you are still planning to invest in Scpharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scpharmaceuticals' history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |